↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

33 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   Actimmune   Interferon gamma-1b   D00747   2件: IFNGR1, IFNGR2   19件: Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Salmonella infection, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis   1件:
326 
 2   Actimmune registry   -   -   -   -   1件:
326 
 3   Ap1903   Ap1903   -   -   -   3件:
60,
285,
326 
 4   Bpx-501 t cells   -   -   -   -   4件:
65,
284,
285,
326 
 5   Busulfan   Busulfan   D00248   -   -   13件:
19,
20,
28,
36,
49,
51,
60,
65,
164,
274,
284,
285,
326 
 6   Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen)   Cyclophosphamide   D00287, D07760   -   -   1件:
326 
 7   Calcitriol   Calcitriol   D00129   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   8件:
37,
46,
49,
66,
96,
158,
235,
326 
 8   Cald hr-d (high-risk, regimen c)   -   -   -   -   4件:
19,
20,
234,
326 
 9   Cald hr-d (high-risk, regimen d)   -   -   -   -   4件:
19,
20,
234,
326 
 10   Cald sr-a (standard-risk, regimen a)   -   -   -   -   4件:
19,
20,
234,
326 
 11   Cald sr-b (standard-risk, regimen b)   -   -   -   -   4件:
19,
20,
234,
326 
 12   Campath, busulfan, clofarabine   Clofarabine   D03546   3件: POLA1, POLA2, RRM1   6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
326 
 13   Campath-1h   Alemtuzumab   D02802   -   -   6件:
19,
20,
60,
234,
285,
326 
 14   Cd34+ enriched, t cell depleted donor stem cell product   -   -   -   -   1件:
326 
 15   Clofarabine   Clofarabine   D03546   3件: POLA1, POLA2, RRM1   6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   9件:
19,
20,
40,
46,
49,
60,
96,
234,
326 
 16   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 17   Cyclophosphamide 30   Cyclophosphamide   D00287, D07760   -   -   3件:
65,
285,
326 
 18   Cyclophosphamide 40   Cyclophosphamide   D00287, D07760   -   -   3件:
65,
285,
326 
 19   Cyclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   16件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
97,
113,
164,
222,
223,
274,
326 
 20   Cyclosporin, methotrexate (gvhd prophylaxis)   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   1件:
326 
 21   Fludarabine   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   17件:
13,
28,
36,
46,
49,
51,
60,
61,
62,
65,
85,
96,
164,
283,
284,
285,
326 
 22   Fludarabine monophosphate   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   4件:
49,
65,
284,
326 
 23   Hematopoetic stem cell transplantation   -   -   -   -   5件:
19,
65,
120,
160,
326 
 24   Imd preparative regimen   -   -   -   -   4件:
19,
20,
234,
326 
 25   Interferon gamma   -   -   -   -   2件:
65,
326 
 26   Interferon gamma-1b   -   -   -   -   7件:
65,
85,
90,
228,
299,
301,
326 
 27   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 28   Osteopetrosis haploidentical only preparative regimen   -   -   -   -   4件:
19,
20,
234,
326 
 29   Osteopetrosis only preparative regimen   -   -   -   -   4件:
19,
20,
234,
326 
 30   Rhpth   Parathyroid hormone   D05364   2件: PTH1R, PTH2R   3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action   3件:
70,
235,
326 
 31   Rimiducid   -   -   -   -   5件:
19,
65,
284,
285,
326 
 32   Stem cell transplantation   -   -   -   -   9件:
13,
19,
20,
46,
65,
90,
164,
234,
326 
 33   Systemic chemotherapy and antibodies   -   -   -   -   2件:
62,
326 

先頭へ